SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007241
Filing Date
2022-05-05
Accepted
2022-05-05 07:53:33
Documents
92
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20220331x10q.htm   iXBRL 10-Q 1832464
2 EX-10.1 tmb-20220331xex10d1.htm EX-10.1 115436
3 EX-10.2 tmb-20220331xex10d2.htm EX-10.2 11462
4 EX-31.1 tmb-20220331xex31d1.htm EX-31.1 10596
5 EX-31.2 tmb-20220331xex31d2.htm EX-31.2 10610
6 EX-32.1 tmb-20220331xex32d1.htm EX-32.1 8318
  Complete submission text file 0001558370-22-007241.txt   8324573

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20220331.xsd EX-101.SCH 81947
8 EX-101.CAL tmb-20220331_cal.xml EX-101.CAL 47434
9 EX-101.DEF tmb-20220331_def.xml EX-101.DEF 393235
10 EX-101.LAB tmb-20220331_lab.xml EX-101.LAB 480012
11 EX-101.PRE tmb-20220331_pre.xml EX-101.PRE 543510
86 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20220331x10q_htm.xml XML 1176964
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39801 | Film No.: 22894132
SIC: 2834 Pharmaceutical Preparations